Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer

Journal of Thoracic Oncology

Volumn 4, Issue 3, 2009, Pages 395-403

  Murthy, Sudish C ^a   Rozas, Maria Solovera ^a   Adelstein, David J ^a   Mason, David P ^a   Calhoun, Royce ^a   Rybicki, Lisa A ^a   Feng, Jingyuan ^a   Blackstone, Eugene H ^a   Rice, Thomas W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Multimodality therapy; Pericardial effusion; Pericarditis; Pleural effusion

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PERICARDITIS; PLEURA EFFUSION; PRIORITY JOURNAL; RADIATION DOSE; SCORING SYSTEM; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; COHORT ANALYSIS; COMPARATIVE STUDY; ESOPHAGUS TUMOR; INCIDENCE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROBABILITY; REFERENCE VALUE; REMISSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PERICARDITIS; PLEURAL EFFUSION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROBABILITY; RADIOTHERAPY, ADJUVANT; REFERENCE VALUES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 67049116496     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318195a625     Document Type: Article

References (29)

1. Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001;233:338-344. (Pubitemid 32187811)
2. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538-543. (Pubitemid 36627845)
3. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467. (Pubitemid 26269945)
4. Keller SM, Ryan LM, Coia LR, et al. High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology Group. Cancer 1998;83:1908-1916.
5. Zhang X, Watson DI, Jamieson GG, Bessell JR, Devitt PG. Neoadjuvant chemoradiotherapy for esophageal carcinoma. Dis Esophagus 2005;18: 104-108. (Pubitemid 40975422)
6. Rice TW, Blackstone EH, Adelstein DJ, et al. N1 esophageal carcinoma: the importance of staging and downstaging. J Thorac Cardiovasc Surg 2001;121:454-464. (Pubitemid 32230213)
7. Murthy SC. Left thoracoabdominal esophagectomy. In Patterson G, Cooper JD, Deslauriers J, et al. (Eds.), Pearson's Thoracic and Esophageal Surgery, Vol.2, 3rd Ed. Philadelphia: Churchill Livingstone, 2008. Pp. 584-589.
8. Adelstein DJ, Rice TW, Becker M, et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997;80:1011-1020. (Pubitemid 27427599)
9. Adelstein DJ, Rice TW, Rybicki LA, et al. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol 2000;18:2032-2039.
10. Adelstein DJ, Rice TW, Rybicki LA, et al. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity. Am J Clin Oncol 2007;30:172-180.
11. Rice TW, Adelstein DJ, Chidel MA, et al. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 2003;126:1590-1596.
12. Blackstone EH. Comparing apples and oranges. J Thorac Cardiovasc Surg 2002;123:8-15.
13. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
14. Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med 2007;26:20-36.
15. Blackstone EH, Naftel DC, Turner ME Jr. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986;81:615-624.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
17. Nelson W. Applied Life Data Analysis. New York: John Wiley, 1982.
18. David HA, Moeschberger ML. The Theory of Competing Risks. New York: Macmillan, 1978.
19. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data, 2nd Ed. Hoboken, New Jersey: John Wiley & Sons, 2002.
20. Kouchoukos NT, Blackstone EH, Doty DB, Hanley FL, Karp RB. Cardiac Surgery. Philadelphia: Churchill Livingstone, 2003. Pp. 323- 324.
21. Bergstralh EJ, Konsanke JL. Computerized Matching of Cases to Controls. Technical report No. 56. Department of Health Science Research. Rochester, MN: Mayo Clinic, 1995.
22. Kelley ST, Coppola D, Karl RC. Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg 2004;8:227-231; discussion 231-232. (Pubitemid 38344154)
23. Gutierrez CA, Just-Viera JO. Clinical spectrum of radiation induced pericarditis. Am Surg 1983;49:113-115.
24. Gross NJ. Pulmonary effects of radiation therapy. Ann Intern Med 1977;86:81-92.
25. Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 1996;27:766-773.
26. Yeh ET, Tong AT, Lenihan DJ, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 2004;109:3122-3131.
27. Pohjola-Sintonen S, Totterman KJ, Salmo M, Siltanen P. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer 1987;60:31-37. (Pubitemid 17083547)
28. Cwikiel M, Albertsson M, Hambraeus G. Acute and delayed effects of radiotherapy in patients with oesophageal squamous cell carcinoma treated with chemotherapy, surgery and pre- and postoperative radiotherapy. Acta Oncol 1994;33:49-53. (Pubitemid 24131686)
29. Luu TD, Gaur P, Force SD, et al. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. Ann Thorac Surg 2008;85:1217-1223, discussion 1223-1224.